Acute Parvovirus B19 Infection Mimicking Congenital Dyserythropoietic Anemia

Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA.
Journal of Pediatric Hematology/Oncology (Impact Factor: 0.9). 03/2004; 26(2):133-5. DOI: 10.1097/00043426-200402000-00017
Source: PubMed


Infection with human parvovirus B19 is known to cause transient erythroid aplasia in children with hemolytic anemia but has also been associated with bone marrow necrosis and morphologic changes suggesting myelodysplasia. The authors describe a previously healthy child who presented with severe hypoplastic anemia. Initial bone marrow aspiration revealed erythroid hyperplasia, dyserythropoiesis, and multinucleated erythroid cells with nuclear budding and bridging, consistent with the diagnosis of congenital dyserythropoietic anemia. Serologic testing documented acute parvovirus infection, and on recovery the correct diagnosis of unsuspected congenital spherocytosis was established. This case expands the spectrum of hematologic disease associated with acute parvovirus infection.

7 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Anemia can be seen in the emergency department both as a primary pathological process or secondary to both medical and surgical diseases. Moreover, acute anemia can occur in children who have been otherwise healthy, who have systemic disease, or who have known hematologic disorders. Anemia may indicate a disorder with a single hematopoietic cell line (eg, red blood cells) or may be associated with changes in multiple cell lines indicative of bone marrow involvement, immunologic disease, peripheral destruction of erythrocytes, or sequestration of cells. Independent of the etiology, prompt diagnosis is predicated on understanding the classifications of anemia, the associated presenting symptoms, and the proper ordering and interpretation of laboratory studies. This article will discuss the evaluation, proper classification, differential diagnosis, and initial management of acute anemia using cases representative of those that might be seen in the pediatric emergency department. Clin Ped Emerg Med 6:124-137 ª 2005 Published by Elsevier Inc.
    Clinical Pediatric Emergency Medicine 09/2005; 6(3):124-137. DOI:10.1016/j.cpem.2005.06.001
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The congenital dyserythropoietic anaemias (CDAs) are a heterogeneous group of diseases in which the anaemia is predominantly caused by dyserythropoiesis and marked ineffective erythropoiesis; three major (types I, II and III) and several minor subgroups have been identified. Additional information on the natural history of these conditions, the beneficial role of splenectomy in CDA type II and efficacy of interferon-alpha in type I have recently been reported. A disease gene has been localised to a chromosomal segment in the three major types and in CDA type I, a disease gene has been identified (CDANI). Mutations have been detected in both familial and sporadic cases but the predicted protein structure gives few clues as to its function. In both type I and II, there are cases unlinked to the identified localisations, suggesting genetic heterogeneity.
    British Journal of Haematology 12/2005; 131(4):431-46. DOI:10.1111/j.1365-2141.2005.05757.x · 4.71 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Parvovirus B19 is a common, self-limiting, usually benign childhood virus that causes erythema infectiosum, also known as fifth disease. Acute infection in pregnancy can cause B19 infection in the fetus, leading to nonimmune fetal hydrops or fetal loss, depending on gestational age at the time of infection. Susceptibility to parvovirus B19 infection should be determined in selected pregnant women at high risk for exposure, and counseling should be provided regarding prevention, testing, and treatment options if exposed.
    Journal of Obstetric Gynecologic & Neonatal Nursing 01/2006; 31(1):107-12. · 1.02 Impact Factor
Show more